BROWN BROTHERS HARRIMAN & CO

Position in HLN — Haleon plc

CIK 14661 NEW YORK, NY

Position in HLN

as of Mar 31, 2026 · filed May 14, 2026 Compact

Position Value

$152,472

+$71,724 QoQ

Shares Held

15,232

+90.7% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Sep 2022

15 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

BROWN BROTHERS HARRIMAN & CO holds $168,196,691 across 13 Drug Manufacturers - Specialty & Generic names. HLN ranks #3 (0.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ZTS	Zoetis Inc.	1,416,566	$167,452,266
2	VTRS	Viatris Inc	29,552	$399,247
3	HLN	Haleon plc This page	15,232	$152,472
4	TAK	Takeda Pharmaceutical Co Ltd	6,812	$126,158
5	UTHR	UNITED THERAPEUTICS Corp	40	$23,719
6	RDY	Dr Reddys Laboratories Ltd	1,000	$13,850
7	SUPN	Supernus Pharmaceuticals, Inc.	187	$9,666
8	COLL	Collegium Pharmaceutical, Inc	243	$8,036

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$152,472	15,232	+90.7%	Shares	Sole	2026-05-14
2025-12-31	$80,748	7,987	-37.5%	Shares	Sole	2026-02-12
2025-09-30	$114,681	12,785	+38.8%	Shares	Sole	2025-11-13
2025-06-30	$95,486	9,208	+21.7%	Shares	Sole	2025-08-11
2025-03-31	$77,885	7,569	0.0%	Shares	Sole	2025-05-14
2024-12-31	$72,208	7,569	-44.6%	Shares	Sole	2025-02-12
2024-09-30	$144,448	13,653	+80.4%	Shares	Sole	2024-11-13
2024-06-30	$62,519	7,569	+21.4%	Shares	Sole	2024-08-09
2024-03-31	$52,935	6,235	-3.3%	Shares	Sole	2024-05-10
2023-12-31	$53,050	6,446	+3.4%	Shares	Sole	2024-02-12
2023-09-30	$51,937	6,235	-10.5%	Shares	Sole	2023-11-13
2023-06-30	$58,366	6,965	-7.0%	Shares	Sole	2023-08-07
2023-03-31	$60,936	7,486	+7.5%	Shares	Sole	2023-05-11
2022-12-31	$55,720	6,965	-33.7%	Shares	Sole	2023-02-09
2022-09-30	$63,993	10,508	—	Shares	Sole	2022-11-14
No filing history on record for this holder in this stock.